Table 1 Baseline characteristics and cardiovascular risk factors of participants among EECP、ISRT and Control groups.

From: Effect of enhanced external counterpulsation versus individual shear rate therapy on the peripheral artery functions

 

EECP (n = 12)

ISRT (n = 13)

Control (n = 10)

P-value

Male (percentage/n)

11 (91.67%)

8 (61.54%)

6 (60.00%)

0.396

Age (year)

63.67 ± 7.19

67.00 ± 6.01

69.90 ± 6.74

0.105

Height (cm)

169.25 ± 7.31

165.46 ± 6.04

163.20 ± 6.76

0.114

Weight (kg)

72.96 ± 7.66

66.77 ± 10.04

63.85 ± 10.78

0.084

BMI (kg/m2)

25.47 ± 2.23

24.27 ± 2.42

23.93 ± 3.51

0.372

Waistline (cm)

94.17 ± 8.82

89.92 ± 7.65

93.30 ± 6.07

0.358

Heart rate (bpm)

78.69 ± 23.85

76.54 ± 13.72

76.80 ± 9.07

0.943

SBP (mmHg)

123.00 ± 23.72

133.92 ± 18.28

137.90 ± 15.80

0.181

DBP (mmHg)

74.46 ± 6.01

79.15 ± 7.50

77.60 ± 6.43

0.209

Smoking(percentage/n)

3 (25.00%)

3 (23.08%)

2 (20.00%)

0.926

Drinking (percentage/n)

1 (8.33%)

3 (23.08%)

0 (0.00%)

0.207

Family history(percentage/n)

5 (41.67%)

3 (23.08%)

2 (20.00%)

0.458

Exercise habits(percentage/n)

9 (75.00%)

7 (53.85%)

3 (30.00%)

0.329

Sleep disorders(percentage/n)

0 (0.00%)

1 (7.69%)

3 (30.00%)

0.067

Coronary artery disease (percentage/n)

6

10

5

0.721

Claudication

5

7

6

0.557

Hypertension(percentage/n)

11 (84.62%)

11 (84.62%)

8 (80.00%)

0.946

II diabetes (percentage/n)

10 (76.92%)

13 (100.00%)

6 (60.00%)

0.051

Hyperlipidemia(percentage/n)

3 (7.69%)

4 (23.08%)

6 (60.00%)

0.309

hs-CRP

3.03 ± 5.88

0.48 ± 0.46

1.05 ± 1.26

0.549

Glycosylated hemoglobin

7.81 ± 2.02

6.87 ± 1.86

7.48 ± 2.07

0.672

Glucose

6.86 ± 2.36

6.23 ± 1.61

7.92 ± 4.02

0.543

Total cholesterol

4.16 ± 0.61

3.78 ± 1.79

4.86 ± 1.11

0.291

Low density lipoprotein

2.41 ± 0.50

2.13 ± 1.13

3.19 ± 0.88

0.087

Uric acid

370.49 ± 95.57

412.39 ± 99.94

442.30 ± 65.92

0.338